Swedish MPA’s responsibilities for medical devices on the increase
This article was originally published in RAJ Devices
Executive Summary
The higher stipends paid by the Swedish government to the Medical Products Agency in recent years have improved patient safety issues linked to the monitoring of medical devices. This is one of the main conclusions drawn by the Swedish Agency for Public Management in its 2008 assessment report of the MPA1. It adds that the requirements of the Product Safety Act of 20042 have also widened the remit of agency in this area.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.